Rare diseases
Investigational molecules
Locations
Ul. Stoleczna 7/200, 15-879 Bialystok, Poland
Clinicmed Daniluk Nowak Sp. k. in Bialystok, Poland specialises in clinical trials of conditions such as Psoriasis, Psoriatic arthropathy, Rheumatoid arthritis, Dermatitis atopic, and other specialisations. This site conducts important research.
The department investigates innovative therapies for immune system diseases, with a strong emphasis on conditions such as rheumatoid arthritis and psoriatic arthritis, aiming to improve joint function and patient quality of life.
Ongoing work includes evaluating biologic agents, biosimilars, and novel small‑molecule inhibitors to achieve better disease control and reduced long‑term complications.
Research at the site targets musculoskeletal diseases, focusing on degenerative joint disorders and bone health, including knee osteoarthritis and osteoporosis, to alleviate pain and preserve mobility.
Studies explore weight‑management strategies, analgesic options, and disease‑modifying treatments that can slow progression and enhance daily functioning.
The clinic’s portfolio includes trials on nutritional and metabolic diseases, particularly addressing metabolic imbalances such as hyperuricemia associated with gout and excess body weight, with the goal of normalizing biochemical markers and supporting healthy lifestyles.
Investigations evaluate uric‑acid‑lowering agents and weight‑reduction interventions that may also lessen joint stress and cardiovascular risk.
Clinical activity also covers respiratory tract diseases, with a focus on patients suffering from moderate‑to‑severe chronic obstructive pulmonary disease, seeking therapies that reduce flare‑ups and improve lung function.
Trials assess novel inhaled compounds and systemic agents designed to decrease exacerbation frequency and enhance overall respiratory health.
The department conducts extensive research on skin and connective tissue diseases, including conditions such as plaque psoriasis, atopic dermatitis, palmoplantar pustulosis, and vitiligo, aiming to provide better symptom control and skin restoration.
Research evaluates emerging immunomodulators, targeted biologics, and topical formulations to achieve clearer skin and durable remission.
Clinical trials currently enrolling participants at this site.
A Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
PolandLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
PolandA study comparing dotinurad and allopurinol for lowering uric acid levels in adults with gout and high uric acid in the blood.
PolandA study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
PolandA Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus
PolandStudy of Delgocitinib Cream for Adults with Mild to Severe Palmoplantar Pustulosis: A 16-Week Treatment Trial
PolandStudy on the Effectiveness of EscharEx and Amnion/Chorion Membrane Allograft for Patients with Venous Leg Ulcers
PolandEfficacy and safety of 6‑grass pollen polymerized extracts 30,000 TU/mL and 10,000 TU/mL in adults with grass pollen‑induced allergic rhinitis/rhinoconjunctivitis, with or without mild‑to‑moderate asthma
PolandA Randomized Dose‑Ranging Study of Nalbuphine Hydrochloride Extended‑Release Tablets in Adults with Refractory Chronic Cough
PolandSafety and Efficacy Study of the Acne mRNA vaccine (mrt1800, mrt1801, mrt1802) in Adults 18‑45 Years with Moderate to Severe Acne
PolandStudy of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
PolandA study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
